Copy For Citation
Kutluğ Ş., Karadağ Ş. İ. K., Gülnar Şensoy S., Birinci A., KÖKER M. Y., Yıldıran A.
JOURNAL OF PEDIATRIC INFECTION, vol.15, no.4, pp.205-211, 2021 (ESCI)
Article / Review
JOURNAL OF PEDIATRIC INFECTION
Emerging Sources Citation Index (ESCI), Scopus, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
Chronic granulomatous disease, invasive fungal disease, primary immunodeficiency disease, prophylaxis, voriconazole, POSACONAZOLE VS. FLUCONAZOLE, INVASIVE FUNGAL DISEASE, ITRACONAZOLE PROPHYLAXIS, ANTIFUNGAL PROPHYLAXIS, PRACTICE GUIDELINES, INFECTIONS, DIAGNOSIS, ASPERGILLOSIS, DEFINITIONS, MANAGEMENT
Erciyes University Affiliated:
Objective: Chronic granulomatous disease (CGD) a primary immunodeficiency disease that affects the innate immune system, and characterized by life-threatening and/or recurrent infections caused by bacteria and fungi. Invasive fungal diseases (IFDs) are the most common causes of death among CGD patients. Itraconazole is usually used for prophylaxis in CGD patients at high risk of IFD. However, patient compliance with oral itraconazole use is low due to gastrointestinal side effects. We aim to report the efficacy of long-term voriconazole prophylaxis for IFD on our CGD patients.